Skip to content

The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children

An Integrative Medical Approach of Acupoint Stimulation for Children With Myopia : A Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02064660
Enrollment
20
Registered
2014-02-17
Start date
2013-12-31
Completion date
2014-12-31
Last updated
2015-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Myopia, Children, Acupressure, Refractive error, Axial length, Korean medicine

Brief summary

Myopia is widely one of the three commonly detected refractive errors. Myopia is usually managed by correction through glasses or contact lenses. Other alternative available include surgery, drugs and acupuncture. There are various therapeutic approaches and different points can be used in acupuncture treatment for myopia, such as auricular acupuncture, acupressure body acupuncture. However, the mechanism of acupuncture therapy for myopia is largely unknown. Furthermore, little information exists regarding the effects and safety of acupuncture for degenerative myopia in children. The investigators aimed to assess the overall effectiveness, safety of periocular acupressure for children with myopia The hypotheses of this study are as follows: Periocular acupressure is effective for myopia progression delay. The study aims to include 56 participants.

Interventions

DEVICEmassager

The patients will be doing self-stimulation using acupressure device, The acupuncture treatment will be applied two times per day for six months. Acupressure divice will stimulate for 14 minutes. Examples of acupuncture points to be used might include GB1, GB14, TE23, ST1, ST2, BL01, BL02, the Extra-point Tae-yang, In-dang.

Sponsors

Korea Institute of Oriental Medicine
CollaboratorOTHER_GOV
Korean Medicine Hospital of Pusan National University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Aged 7-12 years * Spherical equivalent greater than -5D * Individuals without strabismus, anistopia * Willingness to participate in the study

Exclusion criteria

* The presence of a related disease such as cataract, glaucoma, or other eye disease. * Individuals who were received ocular or scalp trauma. * Individuals who were received ocular surgery and had ocular wound. * Individuals who were adapted bifocal lense. * Individuals suffering fever or bad conditions. * Individuals suffering systemic or neurologic disease. * Indibiduals who were receiving other therapy during the period of study * Individuals who did not comply with the treatment which affected myopia progression.

Design outcomes

Primary

MeasureTime frameDescription
Refractive error6 monthsChange from baseline in the refractive erros will be used.

Secondary

MeasureTime frameDescription
Axial length6 monthsChange from baseline in the axial length will be used.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026